BOTULINUM TOXIN PROGRAM

The Australian Government provides subsidised access to botulinum toxin for eligible patients through the Pharmaceutical Benefits Scheme (PBS) Botulinum Toxin Program established under section 100 of the National Health Act 1953. The PBS Botulinum Toxin Program helps eligible patients access PBS subsidised botulinum toxin to assist in the treatment of conditions such as facial spasms, urinary incontinence, chronic migraine and symptoms associated with cerebral palsy.